Alphatec Holdings, Inc. filings document the reporting record of a spine-focused medical technology company. Its Form 8-K disclosures include quarterly and annual operating results, surgical and EOS revenue commentary, non-GAAP profitability measures, preliminary financial information and related press-release exhibits.
The company’s regulatory filings also cover material financing agreements, including senior secured credit facilities, revolving borrowing capacity, term-loan arrangements and references to convertible senior notes. Proxy and governance filings document director elections, board composition, executive and director compensation, equity awards, committee matters and other shareholder voting disclosures.
Alphatec Holdings, Inc. (ATEC) Form 144 shows a proposed sale of 300,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $4,362,000. The shares were originally acquired as restricted stock units on 10/02/2020. The filing lists total outstanding shares of 147,983,775 and an approximate planned sale date of 10/01/2025 on NASDAQ. The notice also discloses a related 10b5-1 sale on 09/02/2025 of 300,000 shares that generated gross proceeds of $4,717,830. The filer certifies they are not aware of any undisclosed material adverse information and references reliance on a trading plan or instruction where applicable.
David Sponsel, Executive Vice President, Sales of Alphatec Holdings, Inc. (ATEC), reported planned sales of common stock under a Rule 10b5-1 trading plan adopted June 12, 2025. The Form 4 shows sales on September 18, 2025 of 137,445 shares at an average price of $15.09 and on September 19, 2025 of 2,555 shares at a weighted average price of $15.34, leaving the reporting person with 531,861 shares beneficially owned after the transactions. The Form 4 was executed by an attorney-in-fact on the reporting dates and discloses that the September 19 price is a weighted average for multiple trades.
Alphatec Holdings, Inc. (ATEC) Form 144 notice: An insider intends to sell 2,555 shares of common stock on approximately 09/19/2025 on NASDAQ with an aggregate market value of $38,887.10 based on the filing. The shares were acquired as restricted stock units (RSUs) on 02/17/2024 and the filer reports the securities were issued by the company. The issuer's total shares outstanding is listed as 147,983,775. The filing also discloses recent 10b5-1 sales by the same person: 137,445 shares sold on 09/18/2025 for $2,073,742.67. The notice includes the standard representation that the selling person does not possess undisclosed material information and references reliance on a trading plan where applicable.
Alphatec Holdings, Inc. (ATEC) submitted a Form 144 notifying the proposed sale of 137,445 common shares through Morgan Stanley Smith Barney LLC on 09/18/2025 with an aggregate market value of $2,020,441.50. The filing shows these shares were acquired on 02/17/2023 as restricted and performance stock units (RSUs & PSUs) from the issuer, and there were no reported sales by the seller in the prior three months.
The shares to be sold represent a small fraction of the 147,983,775 shares outstanding. The filer certifies they are unaware of any undisclosed material adverse information about the issuer. No payment arrangements or gifts are indicated.
Mortimer Berkowitz III, a director of Alphatec Holdings, Inc. (ATEC), reported a sale of common stock on 09/09/2025. The Form 4 shows he disposed of 62,500 shares at a weighted-average price of $15.97, reducing his reported direct beneficial ownership to 618,050 shares. The filing also discloses indirect holdings: 24,802 shares held by spouse and 146,575 shares each attributed to four separate 2016 trusts for Charlotte G., Thomas G., Hayward M., and William W. Berkowitz. The footnotes state the sale occurred in multiple transactions at prices ranging from $15.90 to $16.04 and that the reporting person disclaims beneficial ownership of the spouse-held shares except for pecuniary interest. The Form is signed by an attorney-in-fact on behalf of the reporting person on 09/11/2025.
Miles Patrick, who serves as CEO and a director of Alphatec Holdings, Inc. (ATEC), reported a planned sale of 300,000 shares of ATEC common stock on 09/02/2025 under a Rule 10b5-1 trading plan adopted on June 3, 2025. The sales were executed at a weighted average price of $15.73 with individual transaction prices ranging from $15.53 to $15.96. Following the reported disposition, Mr. Patrick beneficially owned 5,564,078 shares directly, plus 10,900 shares held by an IRA and 250,000 shares held indirectly by MOM, LLC. The Form 4 was filed and signed by an attorney-in-fact on behalf of the reporting person.
Alphatec Holdings, Inc. (symbol ATEC) submitted a Form 144 notifying a proposed sale of 300,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $4,770,000.00. The reported shares were acquired as Restricted Stock Units on 10/02/2020 and the acquisition and payment date is also listed as 10/02/2020. The filing shows 147,983,775 shares outstanding, and an approximate date of sale of 09/02/2025. The filer states there were no securities sold in the past three months for the account and includes the standard representation that the selling person does not possess undisclosed material adverse information.
Alphatec Holdings, Inc. (ATEC) insider sale reported by Chief Operating Officer Lish Scott. The Form 4 shows that on 08/21/2025 the reporting person sold 6,323 shares of Alphatec common stock under a Rule 10b5-1 trading plan adopted March 14, 2025, at a weighted average price of $16.01 per share. After the sale the reporting person beneficially owned 658,707 shares. The filer indicates the price range for the multiple transactions was $16.00 to $16.02 and that full allocation details are available on request. The form was signed by an attorney-in-fact on behalf of the reporting person.
Alphatec Holdings insider sale under 10b5-1 plan. Lish Scott, Chief Operating Officer of Alphatec Holdings, Inc. (ATEC), reported a sale of 9,302 shares of common stock on 08/13/2025 at a price of $16.00 per share. After this transaction the reporting person beneficially owned 665,030 shares, held directly. The filing states the sales were executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, indicating the transactions were prearranged rather than opportunistic trades. The Form 4 was submitted through an attorney-in-fact signature.
Miles Patrick, CEO and Director of Alphatec Holdings, Inc. (ATEC), reported an insider transaction on 08/14/2025. The filing shows a sale of 10,000 common shares and discloses beneficial ownership following the transaction of 5,864,078 shares directly, plus 10,900 shares held in an IRA and 250,000 shares held indirectly by MOM, LLC. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.